Sensei Biotherapeutics has raised $28.5 million to advance a pipeline of personalized cancer drugs. The financing round comes weeks after Sensei shared clinical data on the effect of combining its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results